New SWITCH trial registered pitting apixaban against warfarin in HeartMate 3 patientsNov 5Weekly roundup, 3 itemsAbbott LaboratoriesapixabanUpdated
Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Bristol Myers Squibb raises 2026 guidance, cites pipeline progress across four programsJul 30Quarterly updateBristol Myers Squibbluspatercept